Related Experiment Video

Updated: Apr 27, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.1K

Targeted biopharmaceuticals for cancer treatment

Lufang Zhou1, Ningning Xu2, Yan Sun3

  • 1Departments of Medicine and Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, USA.

Cancer Letters
|July 13, 2014
PubMed

Insights

Targeted anticancer biopharmaceuticals, including monoclonal antibodies and proteins, offer new hope for cancer patients. This review explores their development, applications, and future challenges in combating this genetic disease.

Area of Science:

  • Oncology
  • Biopharmaceutical Development
  • Molecular Biology

Background:

  • Cancer is a major global health challenge driven by genetic mutations.
  • Protein-based biopharmaceuticals have revolutionized cancer treatment, improving patient survival.
  • Targeted therapies offer a more precise approach to cancer treatment.

Purpose of the Study:

  • To review the biological functions and applications of targeted anticancer biopharmaceuticals.
  • To discuss the antigens and pathways crucial for developing targeted cancer therapies.
  • To examine innovative therapeutic agents and future challenges in biopharmaceutical development.

Main Methods:

  • Review of scientific literature on targeted anticancer biopharmaceuticals.
  • Analysis of specific antigens and core pathways in cancer development.
  • Categorization of therapeutic agents including monoclonal antibodies, non-antibody proteins, and small molecules.

Main Results:

  • Identified key antigens and pathways for targeted therapy development.
  • Reviewed diverse classes of targeted anticancer biopharmaceuticals.
  • Highlighted current challenges and potential solutions in the field.

Conclusions:

  • Targeted anticancer biopharmaceuticals represent a significant advancement in cancer care.
  • Continued innovation in biopharmaceutical development is crucial for overcoming treatment challenges.
  • Understanding specific molecular targets is key to effective cancer therapy.
Keywords:
Anticancer biopharmaceuticalsBiosimilarInnovative biologicsTargeted therapy

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

4.9K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K